Gene expression profiling for nitric oxide prodrug JS-K to kill HL-60 myeloid leukemia cells

Jie Liu1, Swati Malavya, Xueqian Wang

  • 1Inorganic Carcinogenesis Section, Laboratory of Comparative Carcinogenesis, National Cancer Institute at NIEHS, Research Triangle Park, NC, USA. Liu6@niehs.nih.gov

Genomics
|April 8, 2009
PubMed

Insights

The anticancer drug JS-K triggers cell death in leukemia by altering gene expression. It activates apoptosis and differentiation pathways, offering potential molecular targets for novel nitric oxide (NO) prodrug therapies.

Area of Science:

  • Molecular Biology
  • Pharmacology
  • Cancer Research

Background:

  • Nitric oxide (NO) prodrugs represent a promising class of anticancer agents.
  • JS-K has demonstrated anticancer activity, necessitating a deeper understanding of its molecular mechanisms.
  • HL-60 leukemia cells are a relevant model for studying cytotoxic effects.

Purpose of the Study:

  • To elucidate the molecular events underlying the anticancer effects of the NO prodrug JS-K.
  • To identify specific gene expression changes induced by JS-K in HL-60 leukemia cells.
  • To explore potential molecular targets for JS-K-based cancer therapies.

Main Methods:

  • HL-60 leukemia cells were treated with varying concentrations and durations of JS-K.
  • Microarray analysis was employed to profile global gene expression changes.
  • Real-time RT-PCR and confocal microscopy were used to validate key gene and protein expression alterations.

Main Results:

  • JS-K induced concentration- and time-dependent changes in gene expression, correlating with cytolethality.
  • Upregulation of apoptotic genes (caspases, Bax, TNF-alpha) and differentiation markers (CD14, ITGAM, VIM) was observed.
  • Modulation of acute phase protein genes (TP53, JUN, c-myc, cyclin E), anti-angiogenesis genes (THBS1, CD36), and tumor cell migration inhibitors was confirmed.
  • Confocal analysis validated key molecular changes at the protein level.

Conclusions:

  • JS-K exerts its anticancer effects through a multifaceted molecular mechanism involving apoptosis and differentiation.
  • The observed gene expression changes highlight potential molecular targets for novel nitric oxide prodrug therapies.
  • JS-K represents a promising novel anticancer NO prodrug with diverse molecular effects on leukemia cells.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Reporter Genes02:11

Reporter Genes

Reporter genes are a type of protein-coding gene that are often tagged to a gene of interest. Once inside a target cell, reporter genes usually produce visually identifiable characteristics like fluorescence and luminescence when expressed along with the gene of interest. Thus, reporter genes “report” the presence or absence of genes of interest in an organism, determine the gene expression pattern, or track the physical location of a DNA segment or protein in the cell.
Commonly used reporter...